Curriculum for endoscopic treatment of esophageal neoplasia and precursor lesions: ESGE Position Statement – with competency assessment tools
Abstract Prior to the start of practical training, the trainee should be aware of different treatment modalities and their specific indications and limitations for patients with esophageal neoplasia and precursor lesions. Before starting the esophageal cancer treatment curriculum, proficiency in management of adverse events such as bleeding, perforation, and strictures, is mandatory. Competency in optical diagnosis of esophageal (pre)neoplastic lesions is a prerequisite to achieve proficiency in the endoscopic management of early esophageal neoplasia. Proficiency in both endoscopic resection and endoscopic ablation is mandatory for being considered competent in the endoscopic management of early Barrett neoplasia. Endoscopic resection in the esophagus should be learned through a structured training program consisting of lectures, live demonstrations, and hands-on training on models, followed by training in humans under strict expert supervision in a hands-on setting. Ideally, a minimum of 10 supervised cases should be done on ex vivo/in vivo models. In order to maintain competence in the endoscopic management of early esophageal neoplasia, an annual caseload of at least 10 new cases per endoscopist with esophageal endoscopic resection and 10 new cases per endoscopist with endoscopic ablation is required.
Authors
- Marcus Hollenbach (ORCID: https://orcid.org/0000-0002-2654-3164)
- David James Tate (ORCID: https://orcid.org/0000-0002-0226-0434)
- Maximilien Barret (ORCID: https://orcid.org/0000-0002-0566-7870)
- Władysław Januszewicz (ORCID: https://orcid.org/0000-0002-8200-2661)
- Stefan Seewald (ORCID: https://orcid.org/0000-0001-8520-5918)
- Roos E. Pouw (ORCID: https://orcid.org/0000-0002-4707-1186)
- Peter Elbe (ORCID: https://orcid.org/0000-0002-6688-0456)
- Pieter Dewint (ORCID: https://orcid.org/0000-0002-1002-9822)
- Jacques J.G.H.M. Bergman (ORCID: https://orcid.org/0000-0001-7548-6955)
- Tony Tham (ORCID: https://orcid.org/0000-0003-3304-0271)
- Franz Ludwig Dumoulin (ORCID: https://orcid.org/0000-0002-1058-7867)
- Vicente Lorenzo‐Zúñiga (ORCID: https://orcid.org/0000-0002-4072-3241)
- Bas L.A.M. Weusten (ORCID: https://orcid.org/0000-0001-9468-4578)
- Adolfo Parra‐Blanco (ORCID: https://orcid.org/0000-0003-2396-0226)
- Raf Bisschops (ORCID: https://orcid.org/0000-0002-9994-8226)
- Yuichi Mori (ORCID: https://orcid.org/0000-0003-2262-0334)
- Emmanuel Coron
- Vladyslav Yakovenko
- Anastasios Manolakis
- Roberta Maselli
Institutions
- Oslo University Hospital (NO)
- Nottingham University Hospitals NHS Trust (GB)
- Karolinska University Hospital (SE)
- Humanitas University (IT)
- Inserm (FR)
- Philipps University of Marburg (DE)
- Ilisimatusarfik (GL)
- Utrecht University (NL)
- Ghent University Hospital (BE)
- Karolinska Institutet (SE)
- University Medical Center Utrecht (NL)
- Hospital Universitari i Politècnic La Fe (ES)
- Klinik Hirslanden (CH)
- Antwerp University Hospital (BE)
- SHOWA Medical University Northern Yokohama Hospital (JP)
- St. Antonius Ziekenhuis (NL)
- University Hospital of Larissa (GR)
- Centre d'Investigation Clinique de Nantes (FR)
- Postgraduate School of Molecular Medicine (PL)
- Gemeinschaftskrankenhaus Havelhöhe (DE)
- Ziekenhuis Oost-Limburg (BE)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Amsterdam University Medical Centers (NL)
- IRCCS Humanitas Research Hospital (IT)
- Antonius Ziekenhuis (NL)
- Bogomolets National Medical University (UA)
- Nantes Université (FR)
Publication Details
- Journal
- Endoscopy
- Published
- 2026-09-24
- DOI
- https://doi.org/10.1055/a-2948-4729
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00